Literature DB >> 12479770

The verdict from ALLHAT--thiazide diuretics are the preferred initial therapy for hypertension.

Lawrence J Appel.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12479770     DOI: 10.1001/jama.288.23.3039

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  28 in total

1.  WNK kinases regulate thiazide-sensitive Na-Cl cotransport.

Authors:  Chao-Ling Yang; Jordan Angell; Rose Mitchell; David H Ellison
Journal:  J Clin Invest       Date:  2003-04       Impact factor: 14.808

2.  Spironolactone and hydrochlorothiazide decrease vascular stiffness and blood pressure in geriatric hypertension.

Authors:  Philip A Kithas; Mark A Supiano
Journal:  J Am Geriatr Soc       Date:  2010-06-01       Impact factor: 5.562

3.  Drug treatment of hypertension: implications of ALLHAT.

Authors:  B Williams
Journal:  Heart       Date:  2003-06       Impact factor: 5.994

4.  Secondary prevention for stroke and transient ischaemic attacks: PROGRESS is about reducing blood pressure, not promoting drugs.

Authors:  Martin Duerden
Journal:  BMJ       Date:  2004-04-10

5.  Clinical studies of thiazide-induced hyponatremia.

Authors:  Kai Ming Chow; Bonnie Ching-Ha Kwan; Cheuk Chun Szeto
Journal:  J Natl Med Assoc       Date:  2004-10       Impact factor: 1.798

Review 6.  Ramipril/felodipine extended-release fixed-dose combination: a review of its use in the management of essential hypertension.

Authors:  Risto S Cvetković; Greg L Plosker
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 7.  Antihypertensive drugs and incidence of type 2 diabetes: evidence and implications for clinical practice.

Authors:  Samuel Asfaha; Raj Padwal
Journal:  Curr Hypertens Rep       Date:  2005-10       Impact factor: 5.369

8.  Efficacy and safety of 24 weeks of therapy with bendroflumethiazide 1.25 mg/day or 2.5 mg/day and potassium chloride compared with enalapril 10 mg/day and amlodipine 5 mg/day in patients with mild to moderate primary hypertension : a multicentre, randomised, open study.

Authors:  S Rasmussen; N Borrild; J Vang Andersen
Journal:  Clin Drug Investig       Date:  2006       Impact factor: 2.859

9.  ASCOT--old or new drugs for blood pressure?

Authors:  James Ritter; John Warren
Journal:  Br J Clin Pharmacol       Date:  2006-03       Impact factor: 4.335

Review 10.  Thiazide effects and adverse effects: insights from molecular genetics.

Authors:  David H Ellison; Johannes Loffing
Journal:  Hypertension       Date:  2009-06-29       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.